Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 May 11;11(2):e15.
doi: 10.2196/jmir.1151.

Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial

Affiliations
Randomized Controlled Trial

Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial

Björn Meyer et al. J Med Internet Res. .

Abstract

Background: Depression is associated with immense suffering and costs, and many patients receive inadequate care, often because of the limited availability of treatment. Web-based treatments may play an increasingly important role in closing this gap between demand and supply. We developed the integrative, Web-based program Deprexis, which covers therapeutic approaches such as behavioral activation, cognitive restructuring, mindfulness/acceptance exercises, and social skills training.

Objective: To evaluate the effectiveness of the Web-based intervention in a randomized controlled trial.

Methods: There were 396 adults recruited via Internet depression forums in Germany, and they were randomly assigned in an 80:20 weighted randomization sequence to either 9 weeks of immediate-program-access as an add-on to treatment-as-usual (N = 320), or to a 9-week delayed-access plus treatment-as-usual condition (N = 76). At pre- and post-treatment and 6-month follow-up, we measured depression (Beck Depression Inventory) as the primary outcome measure and social functioning (Work and Social Adjustment Scale) as the secondary outcome measure. Complete analyses and intention-to-treat analyses were performed.

Results: Of 396 participants, 216 (55%) completed the post-measurement 9 weeks later. Available case analyses revealed a significant reduction in depression severity (BDI), Cohen's d = .64 (CI 95% = 0.33 - 0.94), and significant improvement in social functioning (WSA), Cohen's d = .64, 95% (CI 95% = 0.33 - 0.95). These improvements were maintained at 6-month follow-up. Intention-to-treat analyses confirmed significant effects on depression and social functioning improvements (BDI: Cohen's d = .30, CI 95% = 0.05 - 0.55; WSA: Cohen's d = .36, CI 95% = 0.10 - 0.61). Moreover, a much higher percentage of patients in the intervention group experienced a significant reduction of depression symptoms (BDI: odds ratio [OR] = 6.8, CI 95% = 2.90 - 18.19) and recovered more often (OR = 17.3, 95% CI 2.3 - 130). More than 80% of the users felt subjectively that the program had been helpful.

Conclusions: This integrative, Web-based intervention was effective in reducing symptoms of depression and in improving social functioning. Findings suggest that the program could serve as an adjunctive or stand-alone treatment tool for patients suffering from symptoms of depression.

PubMed Disclaimer

Conflict of interest statement

Dr. Weiss is chief executive officer of the GAIA AG, which is developing products related to the research described in this paper. Björn Meyer was employed by the GAIA AG at the time this research was conducted.

Figures

Figure 1
Figure 1
Example screenshot (see Multimedia Appendix 1 for additional examples)
Figure 2
Figure 2
Participant flow
Figure 3
Figure 3
Program usage over time: comparison between Deprexis participants and similar studies (data from Eysenbach)
Figure 4
Figure 4
Depression severity over time: comparison between the immediate-treatment versus delayed treatment groups (data points are based on all participants who completed questionnaires at each respective time-point)

Similar articles

Cited by

References

    1. Leslie D L, Rosenheck R. Shifting to outpatient care? Mental health care use and cost under private insurance. Am J Psychiatry. 1999 Aug;156(8):1250–7. http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=10450268 - PubMed
    1. Luppa Melanie, Heinrich Sven, Angermeyer Matthias C, König Hans-Helmut, Riedel-Heller Steffi G. Cost-of-illness studies of depression: a systematic review. J Affect Disord. 2007 Feb;98(1-2):29–43. doi: 10.1016/j.jad.2006.07.017.S0165-0327(06)00330-2 - DOI - PubMed
    1. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res. 2003;12(1):22–33. doi: 10.1002/mpr.139. - DOI - PMC - PubMed
    1. Hollon SD, Thase ME, Markowitz JC. Treatment and prevention of depression. Psych. Science in the Public Int . 2002;3(2):39–77. doi: 10.1111/1529-1006.00008. - DOI - PubMed
    1. Andrews GA, Henderson AS. Unmet Need in Psychiatry: Problems, Resources, Responses. Cambridge, UK: Cambridge University Press; 1999.

Publication types

MeSH terms